DEVELOPMENT OF STABILITY INDICATING RP-HPLC METHOD FOR SIMULTANEOUS ESTIMATION OF AMLODIPINE AND OLMESARTAN IN PURE AND PHARMACEUTICAL DOSAGE FORM
Abstract
A precise, accurate, economical and simple stability indicating RP-HPLC method was developed for the estimation of Amlodipine (AML) and Olmesartan (OLM) in bulk and pharmaceutical dosage form. Method was performed on a octadecyl silane column with dimensions 4.6 x 250 mm having particle size 5 micron. The mobile phase used in the method is TEA Buffer (pH 3.0) and acetonitrile in proportion of 25:75 respectively. The flow rate was maintained at 1.0 ml/ min and effluent was monitored at 258 nm. The drug was subjected to acid and alkali hydrolysis, oxidation, photolysis and heat as stress conditions. The method was validated for specificity, linearity, precision, accuracy, robustness and system suitability. The retention times were observed at 2.39 min and 3.33 min for AML and OLM respectively. The standard curve was found linear over a range of 05–35 µg/ml for AML and OLM. Similarly an average correlation coefficient was also obtained at 0.999 for AML and OLM. The limit of quantitation (LOQ) of this method was 2µg/ml for Amlodipine and Olmesartan. The absolute recovery was 100% for Amlodipine and 100.3 for Olmesartan. Degradation products produced as a result of stress studies did not interfere with the detection of AML and OLM and the assay can thus be considered stability-indicating.
Keywords:
Amlodipine, Olmesartan, RP-HPLC, TEA Buffer, Acetonitrile, ValidationDOI
https://doi.org/10.25004/IJPSDR.2018.100504References
2. Swarnkar V, Gill NK, Upadhyay Y, Sharma N, Rawal RK, Sarma GS. UV-Vis Spectrophotometric Method Development and Validation for simultaneous estimation of Amlodipine Besylate, Olmesartan Medoxomil and Hydrochlorothiazide. Inventi journal of pharmacy. 2013; 3:1037.
3. Mundra G, Dubey N, Chaturvedi SC, Jain DK. simultaneous estimation of Amlodipine Besylate, Olmesartan Medoxomil in combined dosage form using UV spectroscopy and RP-HPLC method. International Journal of Biomedical and Pharmaceutical Sciences. 2011; 5(1):49-52.
4. Dhabale PN, Bhagade SR. Simultaneous UV Spectrophotometric Methods for Estimation of Amlodipine Besilate and Olmesartan Medoxomil in Tablet Dosage Form. Journal of Chemical and Pharmaceutical Research. 2011; 3(2):650-656.
5. Jyothirmai B, Tnvss S, Santosh T, Sundar BS. Development and validation of an RP- HPLC method for the determinaton of Olmesartan in human plasma. International journal of research in pharmacy and chemistry. 2014; 4(2): 457-466.
6. Srinivas A, Sneha Y. Stability indicating forced degradation RP-HPLC method development and validation of olmesartan medoxomil. International journal of pharmaceutical sciences and research. 2014; 5(7): 2841-2847.
7. Nalluri BN, Naik DV, Sunandana B, Sushmitha K. Development and validation of RP-HPLC-PDA method for the simultaneous estimation of Hydrochlorothiazide, Amlodipine besylate and Olmesartan medoxomil in bulk and pharmaceutical dosage forms. Journal of Chemical and Pharmaceutical Research. 2013; 5(1):329-335.
8. Rao JR, Rajput MP, Yadav SS, Mulla TS, Bharekar VV. Simultaneous Quantitation of Olmesartan medoxomil, Amlodipine besylate and Hydrochlorothiazide in Pharmaceutical dosage form by using HPLC. International Journal of PharmTech Research. 2011; 3(1): 1435-1440.
9. Jain DK. Development and validation of RP-HPLC method for estimation of amlodipine besylate, olmesartan medoxomil and hydrochlorthiazide in tablet dosage form. International Journal of Research in Ayurveda and Pharmacy. 2014; 5(4):523-530•.
10. Chaitanya KK, Sankar DG, Israel DS. RP-HPLC Method development and validation of Amlodipine and Losartan in binary mixture. Journal of Global Trends in Pharmaceutical Sciences. 2013; 4(3): 1144-1152.
11. Thakker NM, Panchal HB, Rakholiya DR, Murugan R, Choudhari VP, Kuchekar BS. Development and validation of a stability indicating RP-HPLC method for simultaneous estimation of Olmesartan Medoxomil and Metoprolol Succinate in pharmaceutical dosage form. Pharm Methods. 2012; 3(2): 84–89.
12. Patil PS, More HN, Pishwikar SA. RP-¬HPLC Method for simultaneous estimation of Amlodipine besylate and Olmesartan medoxomil from tablet. International Journal of Pharmacy and Pharmaceutical Sciences. 2011; 3(3):146-¬149.
13. Chabukswara AR, Kuchekara BS, Jagdalea SC, Mehetrea DM, Morea AS, Lokhande PD. Development and validation of a RP-HPLC method for simultaneous estimation of Olmesartan Medoxomil and Amlodipine Besylate in tablet dosage form. Scholars Research Library Archives of Applied Science Research. 2010; 2 (4): 307-312.
14. https://www.webmd.com/drugs/2/drug-5891/amlodipine-oral/details
15. https://www.webmd.com/drugs/2/drug-63172/olmesartan-oral/details
16. Draft ICH Guidelines on Validation of Analytical Procedures Definitions and terminology. Federal Register, vol 60. IFPMA, Switzerland, 1995, pp. 1126.
Published
Abstract Display: 532 
PDF Downloads: 0 
